These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 23261003

  • 1. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.
    Pyxaras SA, Sinagra G, Mangiacapra F, Perkan A, Di Serafino L, Vitrella G, Rakar S, De Vroey F, Santangelo S, Salvi A, Toth G, Bartunek J, De Bruyne B, Wijns W, Barbato E.
    Am J Cardiol; 2013 Mar 01; 111(5):684-8. PubMed ID: 23261003
    [Abstract] [Full Text] [Related]

  • 2. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):878-85. PubMed ID: 23703775
    [Abstract] [Full Text] [Related]

  • 3. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H, Kosuge M, Sakamaki K, Kiyokuni M, Ebina T, Hibi K, Tsukahara K, Iwahashi N, Kuji S, Oba MS, Umemura S, Kimura K.
    Heart Vessels; 2017 Jan 15; 32(1):22-29. PubMed ID: 27106917
    [Abstract] [Full Text] [Related]

  • 4. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R.
    Catheter Cardiovasc Interv; 2011 Aug 01; 78(2):198-201. PubMed ID: 20949583
    [Abstract] [Full Text] [Related]

  • 5. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F, Yarlioglues M, Cay S, Celik IE, Mendi MA, Kurtul A, Cankurt T, Kuyumcu S, Canpolat U, Turak O.
    Am J Cardiol; 2015 Sep 01; 116(5):711-6. PubMed ID: 26116992
    [Abstract] [Full Text] [Related]

  • 6. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.
    Am J Cardiol; 2012 Jan 01; 109(1):67-74. PubMed ID: 21943940
    [Abstract] [Full Text] [Related]

  • 7. Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.
    Han B, Li Y, Dong Z, Wan Q, Shen H, Li J, Wei M, Shen C.
    Heart Vessels; 2018 Oct 01; 33(10):1149-1158. PubMed ID: 29704102
    [Abstract] [Full Text] [Related]

  • 8. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Çiçek G, Bozbay M, Açıkgöz SK, Altay S, Uğur M, Köroğlu B, Uyarel H.
    Cardiol J; 2015 Oct 01; 22(1):101-7. PubMed ID: 24671903
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction.
    Liu YH, Liu Y, Zhou YL, He PC, Yu DQ, Li LW, Xie NJ, Guo W, Tan N, Chen JY.
    Am J Cardiol; 2016 Jun 15; 117(12):1896-903. PubMed ID: 27161818
    [Abstract] [Full Text] [Related]

  • 10. Persistent Renal Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.
    Kurogi K, Ishii M, Sakamoto K, Komaki S, Marume K, Kusaka H, Yamamoto N, Arima Y, Yamamoto E, Kaikita K, Tsujita K.
    J Am Heart Assoc; 2019 Dec 03; 8(23):e014096. PubMed ID: 31766973
    [Abstract] [Full Text] [Related]

  • 11. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Lucreziotti S, Centola M, Salerno-Uriarte D, Ponticelli G, Battezzati PM, Castini D, Sponzilli C, Lombardi F.
    Int J Cardiol; 2014 Jun 01; 174(1):37-42. PubMed ID: 24698233
    [Abstract] [Full Text] [Related]

  • 12. Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?
    Ballı M, Taşolar H, Çetin M, Hatem E, Çağlıyan ÇE, Şeker T, Çaylı M.
    J Cardiol; 2016 Apr 01; 67(4):327-30. PubMed ID: 26589269
    [Abstract] [Full Text] [Related]

  • 13. Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial).
    Kaya A, Kurt M, Tanboğa IH, Işik T, Ekinci M, Aksakal E, Kaya Y, Topçu S, Sevimli S.
    Acta Cardiol; 2013 Oct 01; 68(5):489-94. PubMed ID: 24283110
    [Abstract] [Full Text] [Related]

  • 14. Association Between Contrast Media Volume-Glomerular Filtration Rate Ratio and Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Intervention.
    Celik O, Ozturk D, Akin F, Ayca B, Yalcın AA, Erturk M, Bıyık I, Ayaz A, Akturk IF, Enhos A, Aslan S.
    Angiology; 2015 Jul 01; 66(6):519-24. PubMed ID: 25005762
    [Abstract] [Full Text] [Related]

  • 15. Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Ozturk D, Celik O, Erturk M, Kalkan AK, Uzun F, Akturk IF, Akin F, Yildirim A.
    Can J Cardiol; 2016 Feb 01; 32(2):240-6. PubMed ID: 26255218
    [Abstract] [Full Text] [Related]

  • 16. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F, Isorni MA, Halimi JM, Fauchier L, Saint Etienne C, Babuty D, Angoulvant D, Brunet-Bernard A.
    Arch Cardiovasc Dis; 2014 Feb 01; 107(8-9):424-32. PubMed ID: 25082735
    [Abstract] [Full Text] [Related]

  • 17. [Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography].
    Jujo K, Yamaguchi J, Obayashi K, Suzuki K, Sekiguchi H, Nagashima M, Tsurumi Y, Kasanuki H.
    J Cardiol; 2006 Jul 01; 48(1):9-16. PubMed ID: 16886495
    [Abstract] [Full Text] [Related]

  • 18. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH, Xie XJ, Fang Q, Zhang SY, Fang ZJ, Jiang XF, Xie HZ, Liu ZY, Shen ZJ.
    Zhonghua Yi Xue Za Zhi; 2011 Jan 25; 91(4):265-8. PubMed ID: 21418873
    [Abstract] [Full Text] [Related]

  • 19. Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Kim SJ, Choi D, Ko YG, Kim JS, Han SH, Kim BK, Kang SW, Hong MK, Jang Y, Choi KH, Yoo TH.
    Am J Cardiol; 2011 Oct 15; 108(8):1086-91. PubMed ID: 21791335
    [Abstract] [Full Text] [Related]

  • 20. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Kurtul A, Yarlioglues M, Murat SN, Demircelik MB, Acikgoz SK, Ergun G, Duran M, Cetin M, Ornek E.
    Angiology; 2015 May 15; 66(5):433-40. PubMed ID: 24834929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.